QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT). For more information, visit our website at www.qltinc.com.
Looking for a particular QLT Inc. employee's phone or email?
The QLT Inc. annual revenue was $138.4 million in 2026.
Alexander Lussow is the Senior Vice President, Business Development and Commercial Operations of QLT Inc..
27 people are employed at QLT Inc..
QLT Inc. is based in Vancouver, British Columbia.
The NAICS codes for QLT Inc. are [325412, 32541, 541, 54, 325, 3254, 32].
The SIC codes for QLT Inc. are [283, 73, 737, 28].